Past, present and future of drug safety: Editorial.
作者信息
Rieder Michael, Belančić Andrej
机构信息
Department of Paediatrics, University of Western Ontario, London, Ontario, Canada.
Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada.
出版信息
Br J Clin Pharmacol. 2024 Aug;90(8):1760-1762. doi: 10.1111/bcp.16140. Epub 2024 Jun 16.
PMID:38880969
Abstract
摘要
相似文献
1
Past, present and future of drug safety: Editorial.药物安全的过去、现在与未来：社论
Br J Clin Pharmacol. 2024 Aug;90(8):1760-1762. doi: 10.1111/bcp.16140. Epub 2024 Jun 16.
2
[Editorial: adverse drug reactions].[社论：药物不良反应]
Ther Umsch. 2015 Dec;72(11-12):667. doi: 10.1024/0040-5930/a000734.
3
Innovations in Medication Safety: Services and Technologies to Enhance the Understanding and Prevention of Adverse Drug Reactions.药物安全创新：增进对药物不良反应的认识与预防的服务和技术
Pharmacotherapy. 2018 Aug;38(8):782-784. doi: 10.1002/phar.2154. Epub 2018 Jul 22.
4
Adverse drug reactions - preventable or unexpected?药物不良反应——可预防的还是意外发生的？
Curr Drug Saf. 2014 Mar;9(1):1. doi: 10.2174/157488630901140224100800.
5
[Role of Pharmacy in the Promotion of Drug Safety in Pharmacotherapy].[药学在药物治疗中促进用药安全的作用]
Yakugaku Zasshi. 2018;138(2):149-150. doi: 10.1248/yakushi.17-00174-F.
6
Communicating for Drug Safety.促进药物安全的沟通。
Consult Pharm. 2018 Aug 1;33(8):406-408. doi: 10.4140/TCP.n.2018.406.
7
FDA begins active monitoring of drug safety.美国食品药品监督管理局开始对药物安全性进行主动监测。
BMJ. 2008 May 31;336(7655):1211. doi: 10.1136/bmj.a211.
8
Reducing harm to patients caused by avoidable adverse drug reactions.减少可避免的药物不良反应对患者造成的伤害。
Br J Nurs. 2018 Apr 26;27(8):456-457. doi: 10.12968/bjon.2018.27.8.456.
9
Current and future approaches to nonclinical cardiovascular safety assessment.当前和未来的非临床心血管安全性评估方法。
Drug Discov Today. 2020 Jul;25(7):1129-1134. doi: 10.1016/j.drudis.2020.03.011. Epub 2020 Mar 21.
10
Implementing drug safety updates.实施药品安全更新。
Drug Ther Bull. 2014 Jun;52(6):61. doi: 10.1136/dtb.2014.6.0256.
引用本文的文献
1
Pharmacotherapy for Obesity: Recent Updates.肥胖症的药物治疗：最新进展
Clin Pharmacol. 2025 Sep 19;17:305-327. doi: 10.2147/CPAA.S497904. eCollection 2025.
2
Bridging Clinical Outcomes and Cost-Effectiveness: The Role of Real-World Data in Cystic Fibrosis Therapy.连接临床结果与成本效益：真实世界数据在囊性纤维化治疗中的作用。
Pharmacol Res Perspect. 2025 Aug;13(4):e70138. doi: 10.1002/prp2.70138.
3
Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.脊髓性肌萎缩症治疗药物的上市后安全性：基于欧洲药物警戒数据库中自发药物不良反应的分析
J Clin Med. 2025 May 3;14(9):3173. doi: 10.3390/jcm14093173.
Zotero 插件